Skip to content

Stool and Airway Microbiome Signatures Associated With Treatment Response to Dupilumab in Severe Asthma: Findings From the PRISM Study.

Sep 2026 · Allergy. European Journal of Allergy and Clinical Immunology · 0 citations · 48 references
Medicine

TL;DR

Gut and airway-derived microbiomes appear to play complementary roles in severe asthma, and integrating multi-compartment microbiome data may improve the understanding of heterogeneity in biologic treatment response among patients with severe asthma.

Abstract

Background

Severe asthma is characterized by persistent airway inflammation and heterogeneous responses to biologic therapies. Growing evidence implicates the gut-lung axis in asthma pathophysiology; however, few studies have concurrently characterized gut and airway microbiomes in relation to treatment response in severe asthma.

Methods

We profiled microbiomes of stool bacteria (STB), stool-derived extracellular vesicles (STE), and exhaled breath condensate (EBC) from 48 patients with severe asthma receiving dupilumab. Microbial composition, alpha diversity, and predicted functional profiles were compared across sample types and longitudinally according to treatment response. Associations between microbial features and asthma-related clinical markers were also evaluated.

Results

Distinct taxonomic and predicted functional signatures were identified across biological compartments. EBC samples were enriched in Proteobacteria, including Pseudomonas, and exhibited a higher predicted abundance of pathways related to two-component systems and bacterial secretion systems. EBC microbial diversity was positively associated with baseline sputum eosinophil levels (p = 0.018), whereas stool microbial richness demonstrated a time-dependent association with blood eosinophil counts after treatment (p for interaction = 0.023). Treatment responders exhibited lower abundances of Lachnospira (STB q = 0.046; STE q = 0.042) and Escherichia-Shigella (STE q = 0.038), and a higher relative abundance of the Oscillospiraceae NK4A214 group (STB q = 5.5 × 10-7, STE q = 1.4 × 10-8) in stool-derived profiles.

Conclusion

Gut and airway-derived microbiomes appear to play complementary roles in severe asthma. Stool-derived microbial features may reflect systemic inflammatory signals associated with treatment response, whereas airway-derived microbial profiles reflect local airway inflammation. Integrating multi-compartment microbiome data may improve the understanding of heterogeneity in biologic treatment response among patients with severe asthma.

View source

Similar papers

Open access Sep 2026

Bronchial microbiome in severe asthma stratified by blood eosinophil count: an exploratory study of diversity and compositional signals

Asthma is a heterogeneous disease whose pathophysiology underlies distinct inflammatory phenotypes, which in turn influence its clinical course and response to treatment. Neutrophilic inflammation is associated with acute infections and alterations in the microbiome, while data in severe asthma stratified by eosinophil...

E. Vélez-Segovia, Esther Palones, R. del Campo et al. · 0 citations
Open access Sep 2026

A microbiome–metabolome signature associated with pediatric severe asthma

Background Severe asthma is a heterogeneous condition encompassing multiple phenotypes. Understanding lung-specific mechanisms in children with severe asthma may enable the development of more precise therapeutic strategies. We previously reported that immune components in bronchoalveolar lavages (BALs) differentiate c...

Mélanie Briard, B. Guillon, Éric Venot et al. · 0 citations
Open access Oct 2026

Impact of airway microbiome dominance on bronchiectasis severity and inflammation

Airway microbiome composition in bronchiectasis extends beyond conventional microbiology, but its clinical implications remain unclear. This study evaluated the airway bacteriome and mycobiome in bronchiectasis, examining their associations with clinical characteristics, inflammatory patterns and disease aet...

F. Gonçalves-Carvalho, Sara Quero, I. Garcia-Olivé et al. · 0 citations
Open access Oct 2026

Epigenome-Wide Association Study of the Upper-Airway Microbiome Involved in Asthma Exacerbations

Rationale: The role of DNA methylation (DNAm) markers in the upper-airway microbiome related to asthma exacerbations despite inhaled corticosteroid (ICS) treatment is unexplored. Objectives: To identify whole-blood DNAm markers associated with the upper-airway microbiome related to asthma exacerbations despite ICS trea...

E. Castillo-Vargas, M. Martin-Almeida, A. Bozack et al. · 0 citations
Open access Oct 2026

Respiratory and Gastrointestinal Mycobiome Profiles Identify Distinct Patient Clusters Associated with Asthma Control.

PURPOSE The human microbiome contributes to asthma pathogenesis, yet most studies have focused on bacterial communities. This pilot study aimed to characterize fungal communities across multiple body sites in adults with asthma and evaluate whether integrated multisite mycobiome profiles are associated with asthma cont...

Amjad N. Kanj, F. Wireko, Conan Y. Zhao et al. · 0 citations
Open access Oct 2026

Sex-Dependent Microbiome-Metabolome Remodeling Associated with Bacteroides acidifaciens Modulation of Acute Respiratory Distress Syndrome

Acute respiratory distress syndrome (ARDS) is a severe lung disorder influenced by the interplay between the intestinal microbiome, host metabolism, and immune function. We previously found that Bacteroides acidifaciens (BA) has opposing effects on staphylococcal enterotoxin B (SEB)-induced ARDS, worsening the conditio...

S. Staley, C. Cooper, Stacey Oxendine et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.